Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial

PaperCitations, authors & open-access status

The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 145 citations, 2010 year and closed oa status.

145
Citations
2010
Year
closed
OA Status

Related on ScholarIQ

Anders Bonde Jensen
Author
Clinical Breast Cancer
Journal
Bone health and treatments
Topic
Bone health and treatments
Topic
Bone Metabolism and Diseases
Topic
Vitamin K Research Studies
Topic
470M+ articles · free account